**UNITED      STATES **
**SECURITIES AND EXCHANGE COMMISSION**

**Washington,      D.C. 20549**

**FORM      10-QSB**

| **[**Ö**]**                                                                                                                   |   | Quarterly                Report pursuant to Section 13 or 15(d) of the Securities Exchange                Act of                1934 |
|------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                               |   | For                the quarterly period ended May 31, 2007                                                                           |
|                                                                                                                               |
|                                                                                                                               |   |                                                                                                                                 |
| **                               [   ]** |   | TRANSITION                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF                1934                     |
|                                                                                                                               |   | For                the transition period from _______________to                ________________                                      |

**Commission      File No.**
**333-86706**

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

| **Nevada**                                                         |   **7389**                                                    | **98-0375957**                                    |
|--------------------------------------------------------------------|-------------------------------------------------------------------------|---------------------------------------------------|
| (State                or Other Jurisdiction of Incorporation)      | (Primary                Standard Industrial Classification Code Number) | (IRS                Employer Identification. No.) |
|                                                               |                                                                    |                                              |
| **121                WEST SYCAMORE ST., KOKOMO, Indiana 46901**    |
| (Address                of Principal Executive Offices) (Zip Code) |
|                                                               |

** (765)      456-1089**

**None**

**Common Stock, par value      $0.001 per share**

|   | Yes | X | No                _____ |
|--------|-----|---|-------------------------|

|   | Yes | _______ | No                X |
|--------|-----|---------|---------------------|

|   | Yes                     | _______   | No                  X |
|--------|-----------------------------------|---------------------|-----------------------|

----

|                                                                                                      | PAGE   |
|-----------------------------------------------------------------------------------------------------------|--------|
| **PART                  I. FINANCIAL INFORMATION**                                                        |   |
| Item                  1. Financial                  Statements                                            |   |
|                       Consolidated Balance Sheets (unaudited)                         | 3      |
|                       Consolidated Statements of Operations (unaudited)               | 4      |
|                       Consolidated Statements of Cash Flows (unaudited)               | 5      |
|                       Notes to Financial Statements (unaudited)                       | 6      |
|                                                                                                      |   |
| Item                  2. Management’s Discussion and Analysis or Plan of                  Operation | 9      |
| Item                  3. Controls and Procedures                                                          | 9      |
|                                                                                                      |   |
| **PART                  II. OTHER INFORMATION**                                                           | 14     |
|                                                                                                      |   |
| Item                  1. Legal Proceedings                                                                | 14     |
| Item                  2. Unregistered Sales of Equity Securities and Use of                  Proceeds     | 14     |
| Item                  3. Defaults upon Senior Securities                                                  | 14     |
| Item                  4. Submission of Matters to a Vote of Security Holders                              | 14     |
| Item                  5. Other Information                                                                | 14     |
| Item                  6. Exhibits and Reports on Form 8-K                                                 | 14     |
|                                                                                                      |   |
| Signatures                                                                                                | 15     |

----

**NOTE      REGARDING FORWARD-LOOKING STATEMENTS**

**FORWARD-LOOKING      STATEMENTS**

|   | o | our                ability to raise capital,                                                                  |   |
|--------|---|---------------------------------------------------------------------------------------------------------------|--------|
|   | o | our                ability obtain and retain customers,                                                       |   |
|   | o | our                ability to provide our products and services at competitive                rates,          |   |
|   | o | our                ability to execute our business strategy in a very competitive                environment, |   |
|   | o | our                degree of financial leverage,                                                              |   |
|   | o | risks                associated with our acquiring and integrating companies into our                own,     |   |
|   | o | risks                related to market acceptance and demand for our services,                                |   |
|   | o | the                impact of competitive services,                                                            |   |
|   | o | other                risks referenced from time to time in our SEC filings.                                   |   |

----

**PART      I – FINANCIAL INFORMATION**

**ITEM      1. FINANCIAL STATEMENTS**

----

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**CONSOLIDATED      BALANCE SHEETS**

**(unaudited)**

|                                                                                                                                                                |   |   |   |                                                         |   |                                                   |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|--------------------------------------------------------------|--------|--------------------------------------------------------|--------|
| **ASSETS**                                                                                                                                                          |   |   |   |                                                         |   |                                                   |   |
| Current                assets                                                                                                                                       |   |   |   | May                31, 2007                                  |   | February                28, 2007                       |   |
| Cash                                                                                                                                                                |   |   |   | $                     318,359       |   | $                     286,293 |   |
| Accounts                receivable, net of the allowance of $80,558 and $80,558                                                                                     |   |   |   | 54,010                                                       |   | 82,798                                                 |   |
| Deferred                financing costs – current portion                                                                                                     |   |   |   | 55,877                                                       |   | 40,494                                                 |   |
| Prepaid                and other current assets                                                                                                                     |   |   |   | 10,714                                                       |   | 24,974                                                 |   |
| Total                current assets                                                                                                                                 |   |   |   | 438,960                                                      |   | 434,559                                                |   |
| Fixed                assets, net of accumulated depreciation of $141,929 and                $134,014                                                                |   |   |   | 158,103                                                      |   | 150,366                                                |   |
| Deferred                financing costs                                                                                                                             |   |   |   | 71,462                                                       |   | 41,556                                                 |   |
| Other                assets                                                                                                                                         |   |   |   | -                                                            |   | 3,569                                                  |   |
| Total                assets                                                                                                                                         |   |   |   | $                      668,525 |   | $                     630,050 |   |
|                                                                                                                                                                |   |   |   |                                                         |   |                                                   |   |
| **LIABILITIES                AND STOCKHOLDERS’ EQUITY(DEFICIT)**                                                                                              |
| Current                liabilities                                                                                                                                  |   |   |   |                                                         |   |                                                   |   |
| Accounts                payable and accrued liabilities                                                                                                             |   |   |   | $338,747                                                     |   | $275,000                                               |   |
| Stock                payable                                                                                                                                        |   |   |   | 86,774                                                       |   | 112,725                                                |   |
| Notes                payable - related parties                                                                                                                      |   |   |   | 239,252                                                      |   | 249,808                                                |   |
| Lines                of credit                                                                                                                                      |   |   |   | 3,886                                                        |   | 6,594                                                  |   |
| Mandatorily                redeemable Series C Preferred Stock, $.001 par value, 90,000 shares                authorized, issued, and outstanding                   |   |   |   |  75,600                                                 |   | 75,600                                                 |   |
| Derivative                liabilities                                                                                                                               |   |   |   | 80,943                                                       |   | 103,469                                                |   |
| Total                current liabilities                                                                                                                            |   |   |   | 825,202                                                      |   | 823,196                                                |   |
| Callable                secured convertible notes payable                                                                                                           |   |   |   | 1,812,132                                                    |   | 1,433,849                                              |   |
| Total                liabilities                                                                                                                                    |   |   |   | 2,637,334                                                    |   | 2,257,045                                              |   |
|                                                                                                                                                                |   |   |   |                                                         |   |                                                   |   |
| Stockholders'                equity (deficit)                                                                                                                       |   |   |   |                                                         |   |                                                   |   |
| Series                A Convertible Preferred Stock, $.001 par value, 5,000,000 shares                authorized, 0 shares issued and outstanding                   |   |   |   | -                                                            |   | -                                                      |   |
| Series                B Preferred Stock, $.001 par value, 5,000,000 shares authorized,                0 shares                issued and outstanding                |   |   |   | -                                                            |   | -                                                      |   |
| Common                stock, $.001 par valued, 500,000,000 shares authorized, 84,061,857                and                76,561,857 shares issued and outstanding |   |   |   | 84,061                                                       |   | 76,561                                                 |   |
| Additional                paid-in-capital                                                                                                                           |   |   |   | 61,888,404                                                   |   | 61,871,773                                             |   |
| Accumulated                deficit                                                                                                                                  |   |   |   | (63,941,274)                                                 |   | (63,575,329)                                           |   |
| Total                stockholders' (deficit)                                                                                                                        |   |   |   | (1,968,809)                                                  |   | (1,626,995)                                            |   |
| Total                liabilities and stockholders' (deficit)                                                                                                        |   |   |   | $668,525                                                     |   | $630,050                                               |   |
|                                                                                                                                                                |   |   |   |                                                         |   |                                                   |   |

----

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**CONSOLIDATED      STATEMENTS OF OPERATIONS**

**(unaudited)**

|                                                      |    |                                                           |    |                                                                 |
|-----------------------------------------------------------|---------|----------------------------------------------------------------|---------|----------------------------------------------------------------------|
|                                                      |    | Three                Months ended May 31,                      |
|                                                      |    | 2007                                                           |    | 2006                                                                 |
| Revenue                                                   |    | $         203,935 |    |   $        134,063 |
|                                                      |    |                                                           |    |                                                                 |
| General                and administrative expenses        | 481,796 |                                                           | 445,731 |
|    Net                loss from operations |    | (277,861)                                                      |    | (311,668)                                                            |
|                                                      |    |                                                           |    |                                                                 |
| (Gain)/Loss                on derivatives                 |    | (37,100)                                                       |    | 96,848                                                               |
| Registration                rights penalties              |    | -                                                              |    | 48,000                                                               |
| Interest                expense                           |    | 125,184                                                        |    | 76,947                                                               |
|    Net                loss                 |    | $       (365,945)           |    | $        (533,463)           |
|                                                      |    |                                                           |    |                                                                 |
| Basic              and diluted earnings per share         |    | $  (0.00)                                            |    | $  (0.01)                                                  |
|                                                      |    |                                                           |    |                                                                 |
| Weighted                average shares outstanding        |    | 79,692,292                                                     |    | 68,761,857                                                           |
|                                                      |    |                                                           |    |                                                                 |
|                                                      |    |                                                           |    |                                                                 |

----

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**CONSOLIDATED      STATEMENTS OF CASH FLOWS**

**(unaudited)**

|                                                                                                   |                                  | Three                Months ended May 31,                                                    |
|--------------------------------------------------------------------------------------------------------|---------------------------------------|----------------------------------------------------------------------------------------------|
|                                                                                                   |                                  | 2007                                                                                         |   | 2006 |
| CASH                FLOWS FROM OPERATING ACTIVITIES:                                                   |                                  |                                                                                         |   |
| Net                loss                                                                                |                                  | $  (365,945)                                                                       |   | $  (533,463) |
| Adjustments                to reconcile net loss to cash used in operating                activities:  |                                  |                                                                                         |   |   |
| Depreciation                                                                                           |                                  | 7,915                                                                                        |   | 7,486 |
| Deferred                financing costs amortization                                                   |                                  | 9,711                                                                                        |   | 8,334 |
| Convertible                debt discount amortization                                                  |                                  | 72,457                                                                                       |   | 36,619 |
| Stock                options for services                                                              |                                  | 6,430                                                                                        |   | - |
| Imputed                interest                                                                        |                                  | 2,851                                                                                        |   | - |
| (Gain)/Loss                on derivatives                                                              |                                  | (37,100)                                                                                     |   | 96,848 |
| Common                stock  issued for services                                             |                                  | 5,250                                                                                        |   | 4,400 |
| Changes                in assts and liabilities:                                                       |                                  |                                                                                         |   |   |
| Accounts                receivable                                                                     |                                  | 28,788                                                                                       |   | 15,041 |
| Prepaid                and other current assets                                                        |                                  | 17,829                                                                                       |   | - |
| Accounts                payable and accrued liabilities                                                |                                  | 63,747                                                                                       |   | 157,858 |
| Deferred                revenue                                                                        |                                  | -                                                                                            |   | 25,000 |
| Stock                payable                                                                           |                                  | (25,951)                                                                                     |   | - |
| CASH                USED IN OPERATING ACTIVITIES                                                       |                                  | (214,018)                                                                                    |   | (181,877) |
|                                                                                                   |                                  |                                                                                         |   |   |
| CASH                FLOWS FROM INVESTING ACTIVITIES:                                                   |                                  |                                                                                         |   |
| Purchase                of fixed assets                                                                |                                  | (15,652)                                                                                     |   | - |
|                                                                                                   |                                  |                                                                                         |   |   |
| CASH                FLOWS FROM FINANCING ACTIVITIES:                                                   |                                  |                                                                                         |   |
| Net                change in line of credit                                                            |                                  | (2,708)                                                                                      |   | (2,571) |
| Proceeds                from related party advances                                                    |                                  | 3,955                                                                                        |   | 30,727 |
| Repayment                of advances to related parties                                                |                                  | (14,511)                                                                                     |   | (22,989) |
| Proceeds                from convertible debt, net of offering costs                                   |                                  | 275,000                                                                                      |   | - |
| CASH                PROVIDED BY FINANCING ACTIVITIES                                                   | 261,736                               |                                                                                         | 5,167 |
|                                                                                                   |                                  |                                                                                         |   |   |
| NET                CHANGE IN CASH                                                                      |                                  | 32,066                                                                                       |   | (176,710) |
| Cash,                beginning of period                                                               |                                  | 286,293                                                                                      |   | 213,368 |
| Cash,                end of period                                                                     |                                  | $   318,359                                                                   |   | $    36,658 |
| Cash                paid for:                                                                          |                                  |                                                                                         |   |   |
| Interest                                                                                               |                                  | $               - |   | $      24,428 |
| Income                tax                                                                              |                                  |                -  |   |                - |
|                                                                                                   |                                  |                                                                                         |   |   |
| NON-CASH                INVESTING AND FINANCING ACTIVITIES:                                            |                                  |                                                                                         |   |
|        Discount                on convertible debt from derivatives | $     14,574 |                                                                                         | $               - |
|        Conversion                of note payable to common stock    | 9,600                                 |                                                                                         | - |

----

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**NOTES      TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**NOTE      1 – BASIS OF PRESENTATION**

**NOTE      2 - CALLABLE SECURED CONVERTIBLE NOTES PAYABLE**

| 1.   | $800,000                on November 30, 2005 due November 30, 2008, and 1,600,000 warrants                to                purchase common stock at an exercise price of $0.10 per                share; |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.   | $200,000                on August 31, 2006 due August 31, 2009, and 400,000 warrants to purchase                common stock at an exercise price of $0.10 per                share; |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | $200,000                on October 27, 2006 due October 27, 2009, and 400,000 warrants to                purchase                common stock at an exercise price of $0.10 per                share; |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.   | $300,000                on December 12, 2006 due December 12, 2009, and 600,000 warrants                to                purchase common stock at an exercise price of $0.10 per                share; |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.   | $500,000                on February 7, 2007 due February 10, 2010 and 5,000,000 warrants                to                purchase common stock at an exercise price of $0.01 per                share. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 6.   | $330,000                on May 31, 2007 due May 31, 2010 and 5,000,000 warrants to purchase                common                stock at an exercise price of $0.01 per                share. |
|--------|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Debt                arrangement fees                 | $  95,000            |
|------------------------------------------------------|--------------------------------|
| Broker                fees                           | 45,000                         |
| Key                man life insurance single premium |  20,000                   |
| Legal                fees                            | 15,000                         |
| Less:                amortization                    | (47,661)                       |
|  Deferred                financing costs        | $                127,339  |

|                               | Liability                  as of February                  28, 2007                   |   | Discount                  related to additional                  financing     |   | Gain/Loss                  for the three months ended May 31, 2007 |   | Liability                  as of May 31, 2007           |
|------------------------------------|---------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------|--------|--------------------------------------------------------------------|--------|---------------------------------------------------------|
| Convertible                  notes | $             71,936 |   | $            9,694 |   | $       (13,178)                |   | $        68,452 |
| Warrants                           | 31,533                                                                                |   | 4,880                                                                          |   |  (23,922)                                                     |   | 12,491                                                  |
| Total                              | $           103,469            |   | $          14,574            |   | $      (37,100)                      |   | $        80,943 |

| Face                value of convertible notes                                                                               | $     2,330,000  |
|------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|
| Adjustments:                                                                                                                 |                                           |
| Discount                for derivative liability – convertible notes with compound embedded                derivatives | (636,321)                                      |
| Discount                for derivative liability – investors warrant                                                   | (149,509)                                      |
| Conversion                                                                                                                   | (21,758)                                       |
| Amortization                of debt discount                                                                                 | 289,720                                   |
| Convertible                notes balance, as adjusted                                                                        | $     1,812,132  |

**NOTE      3 – COMMON STOCK**

**NOTE      4 – STOCK OPTIONS**

**NOTE      5 – COMMITMENTS**

**NOTE      6 - CONTINGENCY**

**NOTE      7 – SUBSEQUENT EVENTS**

----

**ITEM      2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF      OPERATIONS.**

**BUSINESS      ENVIRONMENT AND EXECUTIVE OVERVIEW**

| u  | **MDPaperFreeTM**                 - This service offering is a service bureau providing integrated                digital                office technologies to the medical provider practice on a managed                services                provisioning basis. The technologies provided include, but are not                limited                to:  a) Electronic Medical Record; b) Secure Document                Management; c) Office Productivity Tools; d) Internet Presence; e)                Data                and Computing Security; f) Information Security; and g)                Back-up/Restore/Contingency                Services. |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | u | **LEAPprn** -                This service offering provides three categories of revenue cycle                management services:  a) Complete billing management services;                b) Shared billing management services wherein the client performs                data                entry only; and, c) Licensed/Hosted billing management software wherein                the client performs all data and payer business processes using our                software. |
|--------|---|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**BUSINESS      ENVIRONMENT**

| ·   | Product-Services |
|--------------------|------------------|

| ·   | Operations |
|--------------------|------------|

| ·   | Financial |
|--------------------|-----------|

**LEAPprn:**

| ·   | We                have added capability in medical billing-revenue cycle management                in the                area of Medicare Part A and Part B billing. This expands our market                to                include therapies (Physical, Occupational & Speech) and facilities                (Hospital, Hospice, Nursing homes,                etc.)  . |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Secure                electronic document and document management has been extended into                the                workflow reducing paper-based                activities. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   |  Automated                remittances is moving into the program logic development phase; which                applies to the complicated rules for contracted rates, 503(c) corporate                billing and other unique compensation                situations. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Significant                upgrades to our proprietary billing management software have been                accomplished in the areas of:  a) Center for Medicare and                Medicaid Services (CMS) directed changes in forms and submissions;                b)                Changes in data definitions as a result of the standardized Electronic                Claims requirements; and, c) Conversion of all medical providers                to the                National Provider Identification                number. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**MDPaperFreeTM:**

| ·   | Communications                bandwidth serving the PaperFree Medical Solutions (PFMS) network                was                dramatically increased by implementing fiber optic channels; replacing                the                former bonded T-1 connections. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   |  Implementation                of full Virtual Private Network (VPN) functionality throughout the                PFMS                Network was completed. This will begin the conversion of all client-site                connectivity to this VPN network. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Technical                Operations completed the integration of the various technologies                from our                software vendor partners into Version 2.0 of the Digital Medical                Office.                Functions provided include: |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| w   | Electronic                Medical Record |
|---------------|------------------------------------------|

| w   | Revenue                Cycle Management/Practice                Management |
|---------------|----------------------------------------------------------------------------|

| w   | Standard                Interfaces for Laboratory, Electronic Prescription,                etc. |
|---------------|-------------------------------------------------------------------------------------------------|

| w   | Electronic                Document Workflow; i.e. Creation, Storage,                Search |
|---------------|--------------------------------------------------------------------------------------------|

| w   | Integrated                Electronic Communications; i.e. Instant Messaging, Electronic Mail,                Electronic Facsimile |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------|

| w   | Web                Meetings |
|---------------|-----------------------------|

| w   | Remote                Desktop Management |
|---------------|------------------------------------------|

| w   | Back-up                & Restore |
|---------------|--------------------------------------|

| w   | Data                and Information Security to meet HIPAA                requirements |
|---------------|----------------------------------------------------------------------------------------|

**Sales      & Marketing:**

**Personnel:**

**Legal-Regulatory:**

**MANAGEMENT      SUMMARY**

**RESULTS      OF OPERATIONS**

**Risk      Factors**

**Unsuccessful      Operating History**

**If      We Do Not Obtain Additional Financing, We Will Not Be Able to Acquire Any      Assets**

|   | *  | Market                  conditions;                               |
|--------|---------|------------------------------------------------------------------------|
|   | *  | Investor                  acceptance of potential business assets; and |
|   | *  | Investor                  sentiment.                              |

----

**If      We Are Unable To Generate Significant Revenues From Our Operations, Our Business      Will Fail.**

**Our      Securities May Be Subject to Penny Stock Regulation.**

**Forward-Looking      Statements**

**Description      of Properties**

**ITEM      3. CONTROLS AND PROCEDURES**

----

**PART      II. OTHER INFORMATION**

**ITEM      1 - LEGAL PROCEEDINGS**

**ITEM      2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF      PROCEEDS**

**ITEM      3 - DEFAULTS UPON SENIOR SECURITIES**

**ITEM      4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS**

**ITEM      5 - OTHER INFORMATION**

**ITEM      6 - EXHIBITS AND REPORTS ON FORM 8-K**

| Exhibit | Description                of Exhibit                                                                                                            |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1    | Certification                of Chief Executive Officer Pursuant to Rule                13a-14(a)/15d-14(a)                                      |
| 31.2    | Certification                of Chief Financial Officer Pursuant to Rule                13a-14(a)/l5d-14(a)                                      |
| 32.1    | Certification                of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley                Act of 2002, 18 U.S.C. 1350 |
| 32.2    | Certification                of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley                Act of 2002, 18 U.S.C. 1350 |

----

**SIGNATURES**

**PAPERFREE      MEDICAL SOLUTIONS, INC**

|                                                         |   |   |                                                         |   |
|--------------------------------------------------------------|--------|--------|--------------------------------------------------------------|--------|
| /s/Stephen                Hawksworth                         |   |   | /s/                Craig S.                Barrow            |   |
| Name:Stephen                Hawksworth                       |   |   | Name:                 Craig S. Barrow                   |   |
| Title:                Chief                Executive Officer |   |   | Title:                Chief                Financial Officer |   |